GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma business
GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma business Reuters
Covered in this story
Analyst targets on GE HealthCare
- Needham: $65.1 → $93 by Oct 2027 · Buy via Investing.com
- RBC Capital Markets: $65.1 → $80 by Oct 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $GEHC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on GE HealthCare →Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.